SCHEMBL29318839

SCHEMBL29318839

COc1ccc(COc2c(F)cc(C(=O)NC[C@H]3CC[C@H](C(=O)O)CC3)c(F)c2F)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
POLB P06746 3/20 0.42
NPC1 O15118 1/20 0.42
GBA1 P04062 1/20 0.42
RAB9A P51151 1/20 0.42
RXFP1 Q9HBX9 1/20 0.42
VCP P55072 1/20 0.42
ALDH1A1 P00352 3/20 0.42
KDM4E B2RXH2 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
HPGD P15428 1/20 0.42
MMP12 P39900 4/20 0.41
TAS2R14 Q9NYV8 1/20 0.41
CXCR3 P49682 1/20 0.41
GSK3B P49841 2/20 0.40
F10 P00742 1/20 0.40
MAPT P10636 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30995319 1.00 MEN1 (0.44) MEN1KMT2APOLBNPC1GBA1
SCHEMBL29318841 0.93 POLB (0.42) MEN1KMT2APOLBNPC1RAB9A
SCHEMBL30970080 0.93 POLB (0.42) MEN1KMT2APOLBNPC1RAB9A
SCHEMBL30995292 0.92 POLB (0.42) POLBNPC1RAB9AVCPALDH1A1
SCHEMBL29318864 0.92 POLB (0.42) POLBNPC1RAB9AVCPALDH1A1
SCHEMBL30970111 0.91 POLB (0.41) MEN1KMT2APOLBNPC1RAB9A
SCHEMBL29318867 0.91 POLB (0.41) MEN1KMT2APOLBNPC1RAB9A
SCHEMBL27390793 0.90 POLB (0.43) POLBNPC1RAB9AALDH1A1HPGD
SCHEMBL29318811 0.90 POLB (0.43) POLBNPC1RAB9AALDH1A1HPGD
SCHEMBL27347826 0.90 POLB (0.54) MEN1KMT2APOLBNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240238425-A1 HSD17B13 Inhibitors and/or Degraders PFIZER INC. (US) 2024-07-18 US disclosed
US-20240238425-A1 HSD17B13 Inhibitors and/or Degraders PFIZER INC. (US) 2024-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240238425-A1 HSD17B13 Inhibitors and/or Degraders HSD17B13, HSD17B3, HSD17B1 MEN1 4182/4885KMT2A 1081/4885POLB 462/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.